Harrow, Inc. Cost of Revenue
Harrow, Inc. (HROW) reported Cost of Revenue of $20.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-10
- Harrow, Inc. cost of goods and services sold for the quarter ending 2026-06-30 was $20.30M, a 25.06% increase year-over-year.
- Harrow, Inc. cost of goods and services sold for the quarter ending 2026-03-31 was $17.16M, a 10.53% increase year-over-year.
- Harrow, Inc. cost of goods and services sold for the quarter ending 2025-12-31 was $18.47M, a 30.65% increase year-over-year.
- Harrow, Inc. cost of goods and services sold for the quarter ending 2025-09-30 was $17.71M, a 47.38% increase year-over-year.
- Harrow, Inc. cost of goods and services sold for fiscal 2025 was $67.93M, a 37.95% increase from fiscal 2024.
- Harrow, Inc. cost of goods and services sold for fiscal 2024 was $49.24M, a 24.23% increase from fiscal 2023.
- Harrow, Inc. cost of goods and services sold for fiscal 2023 was $39.64M, a 56.17% increase from fiscal 2022.
- Harrow, Inc. cost of goods and services sold for fiscal 2022 was $25.38M, a 39.36% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $20.30M 10-Q · filed 2026-08-10 | $37.46M 10-Q · filed 2026-08-10 | $55.92M derived: sum of 3 quarters · filed 2026-08-10 | $73.64M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $17.16M 10-Q · filed 2026-05-11 | $35.63M derived: sum of 2 quarters · filed 2026-05-11 | $53.34M derived: sum of 3 quarters · filed 2026-05-11 | $69.57M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $18.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $36.18M derived: sum of 2 quarters · filed 2026-03-02 | $52.41M derived: sum of 3 quarters · filed 2026-08-10 | $67.93M 10-K · filed 2026-03-02 |
| 2025-09-30 | $17.71M 10-Q · filed 2025-11-10 | $33.94M derived: sum of 2 quarters · filed 2026-08-10 | $49.47M 10-Q · filed 2025-11-10 | $63.60M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $16.23M 10-Q · filed 2026-08-10 | $31.75M 10-Q · filed 2026-08-10 | $45.89M derived: sum of 3 quarters · filed 2026-08-10 | $57.91M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $15.52M 10-Q · filed 2026-05-11 | $29.66M derived: sum of 2 quarters · filed 2026-05-11 | $41.68M derived: sum of 3 quarters · filed 2026-05-11 | $54.22M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $14.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $26.15M derived: sum of 2 quarters · filed 2026-03-02 | $38.69M derived: sum of 3 quarters · filed 2026-03-02 | $49.24M 10-K · filed 2026-03-02 |
| 2024-09-30 | $12.02M 10-Q · filed 2025-11-10 | $24.56M derived: sum of 2 quarters · filed 2025-11-10 | $35.11M 10-Q · filed 2025-11-10 | $46.41M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $12.54M 10-Q · filed 2025-08-11 | $23.09M 10-Q · filed 2025-08-11 | $34.39M derived: sum of 3 quarters · filed 2026-03-02 | $44.46M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $10.55M 10-Q · filed 2025-05-08 | $21.86M derived: sum of 2 quarters · filed 2026-03-02 | $31.92M derived: sum of 3 quarters · filed 2026-03-02 | $41.92M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $11.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $21.37M derived: sum of 2 quarters · filed 2026-03-02 | $31.37M derived: sum of 3 quarters · filed 2026-03-02 | $39.64M 10-K · filed 2026-03-02 |
| 2023-09-30 | $10.07M 10-Q · filed 2024-11-14 | $20.07M derived: sum of 2 quarters · filed 2024-11-14 | $28.34M 10-Q · filed 2024-11-14 | $34.50M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $10.00M 10-Q · filed 2024-08-07 | $18.27M 10-Q · filed 2024-08-07 | $24.44M derived: sum of 3 quarters · filed 2024-08-07 | $31.16M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $8.27M 10-Q · filed 2024-05-13 | $14.44M derived: sum of 2 quarters · filed 2024-05-13 | $21.16M derived: sum of 3 quarters · filed 2024-05-13 | $27.69M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $6.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $12.89M derived: sum of 2 quarters · filed 2024-03-19 | $19.42M derived: sum of 3 quarters · filed 2024-03-19 | $25.38M 10-K · filed 2024-03-19 |
| 2022-09-30 | $6.72M 10-Q · filed 2023-11-13 | $13.26M derived: sum of 2 quarters · filed 2023-11-13 | $19.22M 10-Q · filed 2023-11-13 | $24.30M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $6.53M 10-Q · filed 2023-08-09 | $12.50M 10-Q · filed 2023-08-09 | $17.58M derived: sum of 3 quarters · filed 2023-08-09 | $22.52M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $5.96M 10-Q · filed 2023-05-11 | $11.04M derived: sum of 2 quarters · filed 2023-05-11 | $15.99M derived: sum of 3 quarters · filed 2023-05-11 | $20.41M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $5.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $10.03M derived: sum of 2 quarters · filed 2023-03-23 | $14.44M derived: sum of 3 quarters · filed 2023-03-23 | $18.21M 10-K · filed 2023-03-23 |
| 2021-09-30 | $4.95M 10-Q · filed 2022-11-14 | $9.36M derived: sum of 2 quarters · filed 2022-11-14 | $13.13M 10-Q · filed 2022-11-14 | $17.07M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $4.42M 10-Q · filed 2022-08-09 | $8.19M 10-Q · filed 2022-08-09 | $12.12M derived: sum of 3 quarters · filed 2022-08-09 | $15.82M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $3.77M 10-Q · filed 2022-05-05 | $7.71M derived: sum of 2 quarters · filed 2022-05-05 | $11.40M derived: sum of 3 quarters · filed 2022-05-05 | $14.61M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $3.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $7.63M derived: sum of 2 quarters · filed 2022-03-10 | $10.84M derived: sum of 3 quarters · filed 2022-03-10 | $14.46M 10-K · filed 2022-03-10 |
| 2020-09-30 | $3.70M 10-Q · filed 2021-11-09 | $6.90M derived: sum of 2 quarters · filed 2021-11-09 | $10.53M 10-Q · filed 2021-11-09 | $14.09M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $3.20M 10-Q · filed 2021-08-10 | $6.83M 10-Q · filed 2021-08-10 | $10.39M derived: sum of 3 quarters · filed 2021-08-10 | $14.46M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $3.63M 10-Q · filed 2021-05-11 | $7.19M derived: sum of 2 quarters · filed 2021-05-11 | $11.25M derived: sum of 3 quarters · filed 2021-05-11 | $16.48M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $7.63M derived: sum of 2 quarters · filed 2021-03-08 | $12.85M derived: sum of 3 quarters · filed 2021-03-08 | $16.75M 10-K · filed 2021-03-08 |
| 2019-09-30 | $4.06M 10-Q · filed 2020-11-09 | $9.29M derived: sum of 2 quarters · filed 2020-11-09 | $13.18M 10-Q · filed 2020-11-09 | $17.29M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $5.22M 10-Q · filed 2020-08-10 | $9.12M 10-Q · filed 2020-08-10 | $13.22M derived: sum of 3 quarters · filed 2020-08-10 | $17.42M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $3.90M 10-Q · filed 2020-05-11 | $8.00M derived: sum of 2 quarters · filed 2020-05-11 | $12.19M derived: sum of 3 quarters · filed 2020-05-11 | $16.35M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $8.29M derived: sum of 2 quarters · filed 2020-03-13 | $12.45M derived: sum of 3 quarters · filed 2020-03-13 | $16.52M 10-K · filed 2020-03-13 |
| 2018-09-30 | $4.19M 10-Q · filed 2019-11-13 | $8.35M derived: sum of 2 quarters · filed 2019-11-13 | $12.42M 10-Q · filed 2019-11-13 | $15.88M derived: sum of 4 quarters · filed 2019-11-13 |
| 2018-06-30 | $4.16M 10-Q · filed 2019-08-14 | $8.23M 10-Q · filed 2019-08-14 | $11.69M derived: sum of 3 quarters · filed 2019-08-14 | $15.09M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $4.07M 10-Q · filed 2019-05-09 | $7.53M derived: sum of 2 quarters · filed 2019-05-09 | $10.93M derived: sum of 3 quarters · filed 2019-05-09 | $14.22M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $6.86M derived: sum of 2 quarters · filed 2019-03-12 | $10.15M derived: sum of 3 quarters · filed 2019-03-12 | $13.51M 10-K · filed 2019-03-12 |
| 2017-09-30 | $3.40M 10-Q · filed 2018-11-13 | $6.69M derived: sum of 2 quarters · filed 2018-11-13 | $10.05M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $3.29M 10-Q · filed 2018-08-06 | $6.64M 10-Q · filed 2018-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |